Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 9, 2014, Pages 1562-1568

  Lammert, Craig ^a   Juran, Brian D ^a   Schlicht, Erik ^a   Xie, Xiao ^b   Atkinson, Elizabeth J ^b   De Andrade, Mariza ^b   Lazaridis, Konstantinos N ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

Biliary inflammation; Caffeine; Cholestasis; Risk factor; UC

Indexed keywords

ADULT; AGED; ARTICLE; COFFEE; CONTROLLED STUDY; DRINKING BEHAVIOR; EDUCATIONAL STATUS; FEMALE; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROCTOCOLECTOMY; QUESTIONNAIRE; SMOKING; ULCERATIVE COLITIS; CROHN DISEASE; NORTH AMERICAN; OBSERVATIONAL STUDY; RISK FACTOR; CHOLANGITIS, SCLEROSING; COHORT ANALYSIS; FEEDING BEHAVIOR; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; NORTH AMERICA;

COFFEE;

ADULT; AGED; CHOLANGITIS, SCLEROSING; COFFEE; COHORT STUDIES; FEEDING BEHAVIOR; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; NORTH AMERICA; SURVEYS AND QUESTIONNAIRES;

EID: 84906790686     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.12.036     Document Type: Article

References (30)

1. Matsuura H., Mure K., Nishio N., et al. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. JEpidemiol 2012, 22:160-166.
2. Andersen L.F., Jacobs D.R., Carlsen M.H., et al. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 2006, 83:1039-1046.
3. Pan A., Malik V.S., Hao T., et al. Changes in water and beverage intake and long-term weight changes: results from three prospective cohort studies. Int J Obes (Lond) 2013, 37:1378-1385.
4. Noordzij M., Uiterwaal C.S., Arends L.R., et al. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. JHypertens 2005, 23:921-928.
5. Freedman N.D., Park Y., Abnet C.C., et al. Association of coffee drinking with total and cause-specific mortality. NEngl J Med 2012, 366:1891-1904.
6. Klatsky A.L., Armstrong M.A. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 1992, 136:1248-1257.
7. Ruhl C.E., Everhart J.E. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005, 128:24-32.
8. Tverdal A., Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 2003, 13:419-423.
9. Modi A.A., Feld J.J., Park Y., et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010, 51:201-209.
10. Bravi F., Bosetti C., Tavani A., et al. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol 2013, 11:1413-1421.
11. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. NEngl J Med 2005, 353:1261-1273.
12. Broome U., Olsson R., Loof L., et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996, 38:610-615.
13. Farrant J.M., Hayllar K.M., Wilkinson M.L., et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991, 100:1710-1717.
14. Juran B.D., Hirschfield G.M., Invernizzi P., et al. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet 2012, 21:5209-5221.
15. Lammert C., Nguyen D.L., Juran B.D., et al. Questionnaire based assessment of risk factors for primary biliary cirrhosis. Dig Liver Dis 2013, 45:589-594.
16. Juran B.D., Atkinson E.J., Schlicht E.M., et al. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis. Liver Int 2011, 31:785-791.
17. Lindor K.D., Gershwin M.E., Poupon R., et al. Primary biliary cirrhosis. Hepatology 2009, 50:291-308.
18. Zein C.O., Beatty K., Post A.B., et al. Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment. Hepatology 2006, 44:1564-1571.
19. Cigarette smoking among adults: United States, 2004. MMWR Morb Mortal Wkly Rep 2005, 54:1121-1124.
20. Andersen I.M., Tengesdal G., Lie B.A., et al. Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2014, 12:1019-1028.
21. Weinstock G.M. Genomic approaches to studying the human microbiota. Nature 2012, 489:250-256.
22. Liu J.Z., Hov J.R., Folseraas T., et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 2013, 45:670-675.
23. Blackwell C.C., Jonsdottir K., Hanson M., et al. Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet 1986, 2:284-285.
24. Thom S.M., Blackwell C.C., MacCallum C.J., et al. Non-secretion of blood group antigens and susceptibility to infection by Candida species. FEMS Microbiol Immunol 1989, 1:401-405.
25. Nakayama T., Oishi K. Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses. FEMS Microbiol Lett 2013, 343:161-168.
26. Tangney C.C., Rasmussen H.E. Polyphenols, inflammation, and cardiovascular disease. Curr Atheroscler Rep 2013, 15:324.
27. Vitaglione P., Morisco F., Mazzone G., et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010, 52:1652-1661.
28. Swanson J.A., Lee J.W., Hopp J.W. Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal. Addict Behav 1994, 19:229-256.
29. Loftus E.V., Sandborn W.J., Tremaine W.J., et al. Primary sclerosing cholangitis is associated with nonsmoking: a case-control study. Gastroenterology 1996, 110:1496-1502.
30. Cohen A.B., Lee D., Long M.D., et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci 2013, 58:1322-1328.